Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease - Cardoso, Barbara R.; Roberts, Blaine R.; Malpas, Charles B.; Vivash, Lucy; Genc, Sila; Saling, Michael M.; Desmond, Patricia; Steward, Christopher; Hicks, Rodney J.; Callahan, Jason; Brodtmann, Amy; Collins, Steven; et al. (Neurotherapeutics, 2019)
Keywords: Aged; Alzheimer Disease - blood; Alzheimer Disease - cerebrospinal fluid; Alzheimer Disease - drug therapy; Alzheimer's disease; Antioxidants; Antioxidants - administration & dosage; Antioxidants - metabolism; Biomedical and Life Sciences; Biomedicine; Central nervous system; Central Nervous System - drug effects; Central Nervous System - metabolism; Cerebrospinal fluid; Clinical trials; Cognitive ability; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Middle Aged; Nervous system; Neurobiology; Neurodegeneration; Neurology; Neurosciences; Neurosurgery; Original; Original Article; Pilot Projects; randomized controlled trial; Selenic Acid - administration & dosage; Selenic Acid - blood; Selenic Acid - cerebrospinal fluid; Selenium; Selenium - administration & dosage; Selenium - blood; Selenium - cerebrospinal fluid; Selenoproteins; Sodium; Sodium selenate; supranutritional selenium supplementation; Trace Elements - administration & dosage; Trace Elements - blood; Trace Elements - cerebrospinal fluid; Sodium selenate; selenium; supranutritional selenium supplementation; Alzheimer's disease; randomized controlled trial; Alzheimer’s disease